Hosted by: NAHEWD
Presenter: Albert Garcia-Romeu, Ph.D.
Description: As clinical trials of psychedelic-assisted therapies progress, the potential of approved psilocybin and MDMA-assisted treatments for anxiety, mood, and substance use disorders (SUDs) looks increasingly promising. Clinicians interested in new mental healthcare treatment options for SUDs can learn about current treatment designs and published study outcomes to consider how psychedelic-assisted therapies might serve people at risk for and living with HIV.
Event Type: Webinar
Continuing Education Credit: CEs will be offered.